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ABSTRACT
Traditionally, herbs of Mimosa pudica L. are being used 
to treat insomnia, hematuria, inflammation, emesis, 
dismenorrhoea, menorrhagia, arthritis rhematoid, con-
vultion, depresion, and diabetes. Previous in vitro study 
showed that herbs extract of Mimosa pudica L inhibited 
uric acid formation via xanthine oxidase inhibition of 
82.11 and 62.10% for concentration of 125 and 62.5 µg/
mL, respectively. Hyperuricemia is indicated by pain and 
oedema which are the symptoms of inflammation. This in 
vivo study was perfor-med to screen antihyperuricemia 
activity of herbs extract of Mimosa pudica L through 
analgesic and antiinflammatory assays on mice. 
Analgesic activity of Mimosa pudica L herb extract at 
dosage of 125, 250 and 500 mg/kg of body weight was 
observed on mice using writhing reflex method with 
acetic acid 0,07 % as inducer. The results showed that 
all three dosages inhibited pain at the percentage of 
9.58, 45.35, and 60.28% respectively. Antiinflammatory 
activity assay was done using carageenan-induced paw 
edema method on white male rats. Dosages used were 
250, 500 and 1000 mg/kg of body weight. The results 
showed that all three dosages inhibited edema at the 
percentages of 35.20, 42.74, and 51.10% respectively. It is 
concluded that herbs extract of Mimosa pudica L can be 
proposed as an antihyperuricemia.
Keywords: Antihyperuricemia, Analgesic, Anti-inflam-
matory, Mimosa pudica L.
ABSTRAK
Secara tradisional, herbal Mimosa pudica L. sedang di 
gunakan untuk mengobati insomnia, hematuria, pera-
dangan, emesis, dismenorrhoea, menorrhagia, arthritis 
rhematoid, convultion, depresi, dan diabetes. Penelitian 
sebelumnya menunjukkan bahwa in vitro herbal ekstrak 
Mimosa pudica L. menghambat pembentukan asam urat 
melalui penghambatan xantin oksidase 82,11 dan 62,10% 
pada konsentrasi 125 dan 62,5 mg/mL, Hyperuricemia 
ditandai dengan rasa sakit dan edema yang merupakan 
gejala peradangan. Penelitian in vivo dilakukan untuk 
menyaring antihyperuricemia aktivitas herbal ekstrak 
Mimosa pudica L. melalui uji analgesik dan antiinflamasi 
pada tikus. Aktivitas analgesik Mimosa pudica L. ramuan 
ekstrak pada dosis 125, 250 dan 500 mg/kg berat badan 
diamati pada tikus menggunakan metode menggeliat 
refleks dengan asam asetat 0,07% sebagai induser. 
Hasil penelitian menunjukkan bahwa ketiga dosis 
menghambat rasa sakit pada persentase 9,58, 45,35, dan 
60,28% masing. Uji aktivitas antiinflamasi dilakukan 
dengan metode edema kaki karagenan-diinduksi pada 
tikus putih jantan. Dosis yang digunakan adalah 250, 
500 dan 1000 mg / kg berat badan. Hasil penelitian 
menunjukkan bahwa ketiga dosis menghambat edema 
pada persentase 35,20, 42,74, dan 51,10% masing. Hal 
ini disimpulkan bahwa herbal ekstrak Mimosa pudica L 
dapat diusulkan sebagai antihyperuricemia. 
Kata kunci: Antihyperuricemia, Analgesik, Anti-infla-
masi, Mimosa pudica L.
INTRODUCTION
NSAIDs used in the inflammatory conditions 
do not cure and remove the underlying cause of 
the disease but they only modify the inflammatory 
response to the disease. Large numbers of NSAIDs 
are available in the market with their advantages 
and disadvantages. Though there are standard 
drugs like Aspirin, Indomethacin, Phenylbutazone, 
etc., these drugs are not entirely free of side 
effects and have their own limitation. Thus there 
is still a need to develop newer and safer anti-
inflammatory drugs. NSAIDs use is frequently 
limited by gastrointestinal side effects, ranging 
from dyspepsia to life threatening bleeding from 
ulceration. It is believed that NSAIDs by inhibiting 
COX pathway causes inhibition of prostaglandins 
synthesis, which are responsible for maintaining 
gastric mucosal integrity.  Herbal medicines used 
in Ayurveda remain the major source of health care 
for the world’s population. 
WHO has recognized herbal medicine as an 
essential building block for primary health care 
of vast countries like India. Traditionally, herbs 
of Mimosa pudica L. are being used in insomnia, 
hematuria, inflamation, emesis, dismenorrhoea, 
menorrhagia, arthritis rhematoid, convultion, 
depresion, and diabetes. It has been reported that 
herbs of Mimosa pudica L. have diureticum, anti 
diabetic and antioxidant activity. (Perry, 1987)  Also 
herbs  of Mimosa pudica are rich  in mimosine 
(N-(3-alanyl) -3-hydroxy-4-piridone), norepinefrine, 
linoleneic acid , oleic acid, palmitic acid,  stearic 
acid, phenol, amino acid, steroid/triterpenoid, 
sterol, tannins, and  flavonoids, 4“-hydroxymycine, 
dan cassiaocidentalin B (Bum, 2004). While in 
Central Java leaves of Mimosa pudica L. are being 
used to cure insomnia.Therefore, by considering 
the traditional claim, chemical constituents and 
reported activities of Mimosa pudica L. this study 
was planned to screen antihyperuricemia activity of 
herbs extract of Mimosa pudica L. by using analgesic 
and antiinflammatory assay methods (Bum, 2004; 
Dalimarta, 2003; Kasahara, 1995).
MATERIALS AND METHODS
Collection of plants
Herbs of Mimosa pudica L. were collected 
from areas around Bandung, West Java, Indonesia. 
These herbs  were identified and authenticated 
in Botanical Taxonomy Laboratory, Department 
of Biology,  Universitas Padjadjaran, West Java, 
Indonesia.  
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Preparation of extract
After 10 days of indoor drying process, the 
herbs were coarsely powdered using a mixer. The 
powder was sieved using 40 mesh sieve. About 
500 g of dried powder of the herbs were extracted 
with ethanol for 72 h. The extract was concentrated 
and dried (yield - 8% w/w). The dried ethanolic 
extract was kept in airtight container in desic cator 
and used throughout the study.
Experimental section
Male ICR mice of 15-20 g weigh and Wistar 
albino rats of 150-200 g weigh were housed in 
standard cages at room temperature for 1 week 
before the experiments. Animals were provided 
with standard rodent pellet diet, and water ad. 
libitum. The animals were deprived of food for 
24 hours before treatment, but had free access to 
drinking water. All experiments were performed 
in the morning. (Musa, et al., 2009)
Analgesic activity
Writhing test
For writhing behavior testing, 0.7% acetic 
acid solution 10 mL/kg of body weight was 
injected i.p., and the number of writhing and 
stretching movements was counted over a 5-min 
period as described by Hendershot and Forsaith, 
1959. Writhing is defined as contraction of the 
abdominal muscles accompanied by extension of 
the hind limbs. The extract at the dosage of 125, 
250 and 500 mg/kg bw, p.o. was administered 60 
min before acetic acid. The percentage inhibition 
was determined for each experimental group 
(Madina, 1999; Subarnas and Wagner, 2000).
Acetic Acid-Induced Writhing Test. 
The writhing testing mice was conducted 
as described in the previous study. Male ICR 
mice (five per group) were fasted for 24 h 
before the experiment, with free access to water. 
The writhes were induced by intraperitoneal 
injection of 1.0% acetic acid in distilled water 
(0.1 mL/10 g body weight). Three dosages were 
chosen (0.125, 0.250, and 0.500 g/kg of body 
weight). Mice were administered orally with the 
extract  (0.125, 0.250, and 0.500 g/kg) suspensed 
in gum Arabic (PGA) 60 min prior to chemical 
induction of writhes and the same volume of 
PGA suspensed by oral administration as the 
vehicle control. Aspirin (65mg/kg, p.o.) was 
administered 30 minutes prior to acetic acid 
injection. Mice were placed in an observation box 
separately and the number of writhing responses 
was counted within 60 minutes (Ntandou et al., 
2010; Ozbek, 2005; Hajhashemi et al., 2003)
Antiinflammatory activity
Carrageenan-induced paw edema test: Inflam-
mation was induced by administering 0.1 mL 
of (1%) carrageenan into sub-plantar surface of 
rat hind paw. Albino rats of weighing 150-250 
g were fasted overnight with ad. libitum access 
to water. The animals were divided in to five 
groups (n=3).
Group I :  PGA suspension (2% )
Group II : Indomethacin (10 mg/kg, p.o.) in PGA 
suspension  
Group III : Ethanolic extract of Mimosa pudica 
L.(250 mg/kg, p.o.) in PGA suspension
Group IV : Ethanolic extract of Mimosa pudica 
L.(500 mg/kg, p.o.) in PGA suspension
Group V : Ethanolic extract of Mimosa pudica 
L.(1000 mg/kg, p.o.) in PGA suspension
In this experiment, all drugs were given 
orally. One hour after drug treatment all animals 
were injected with 0.1 mL of 1% carrageenan 
solution in the sub-plantar aponeurosis of left 
hind paw and the paw volume was measured 
plethysmometrically at 1 h, 2 h, 3 h, 4 h, and 5 h. 
Results were expressed as,
Edema Volume = Vt-Vc
Vt= Paw volume in mL, at time t, after 
carrageenan administration.
Vc= Paw volume in mL, before carrageenan 
administration.
Inhibition rate (%) = Ec-Et / Ec × 100
Ec = edema volume of control group.
Et = edema volume of treated group.
RESULTS AND DISCUSION
Analgesic Effect of Ethanolic Extract Mimosa 
pudica L. on Writhing Reflex of Mice. 
The results of the analgesic activity of 
ethanolic extract of Mimosa pudica L. can be seen 
in Table 1.
Amount of writhing decreased in time and 
dose dependent manner. It can be predicted 
that the decreasing of writhing due to analgesic 
activity of some chemical compounds in the 
extract. Treatment of Mimosa pudica L. extract 
at 0.125, 0.250 and 0.500 g/kg and aspirin 65 
mg/kg of body weight showed the decreasing 
of writhing compared to the negative control 
(P <0.01) with percentage of pain protection as 
shown in Table 2. 
Mimosa pudica L. extract at dosage 0.500 g/
kg of body weight showed the best percentage of 
pain protection (60.28%).
Antiinflammatory Effect Ethanolic Extract of 
Mimosa pudica L. on Carrageenan Induced 
Hind Paw Edema on Rats
Inhibition of carrageenan induced hind paw 
edema on rats by indomethacine  started at 1st 
hour and which was maintained up to 5th hour. 
Indomethacine at the dosage of 10 mg/kg average 
at 1st, 2nd, 3rd , 4th, 5th hour has shown 73.71% 
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Table 1. Amount of writhing in 60 minutes of observation
Group
Average amount of writhing in 60 minutes observation 
Total
5’ 10’ 15’ 20’ 25’ 30’ 35’ 40’ 45’ 50’ 55’ 60’
Dosage 125 mg/kg of 
body weight
24.8 26.4 21.2 18.6 16 15.6 12.2 11.2 9.6 10.8 8.6 8 183
Dosage 250 mg/kg of 
body weight
19.6 16.2 13 10.4 10 9.4 8.4 6.2 4.8 4.6 4.2 3.8 110.6
Dosage 500 mg/kg of 
body weight
13.4 16.8 10.6 9 6 5.8 5.6 1.8 3.2 2.8 3.2 2.4 80.4
Negative Control 39.4 27.6 23 17 15.2 15.8 14 12.8 10.2 10.4 7.8 9.2 202.4
Positive Control           13.8   16.4 12.2 11.2 10.4 7.6 7.2 4.8 3.6 2.2 2.4 3 94.8
Table 2. Protection Percentage Towards Pain of each Test 
Groups of Ethanolic Extracts of Mimosa pudica L.
Test groups Dosage (mg/kg of body weight)
Pain Protection 
(%)
Aspirin 65 53
Mimosa pudica 
L. Extract
125 9.58
Mimosa pudica 
L. Extract
250 45.35
Mimosa pudica 
L. Extract
500 60.28
inhibition, respectively. At 3rd hour, the ethanolic 
extract of Mimosa pudica L. at the dosage of 250, 
500 and 1000 mg/bw has shown 35.20, 13.44 and 
31.18% inhibition, respectively. The results of 
this work are shown in Table 3.
It can be seen that ethanolic extract of 
Mimosa pudica L. at the dosage of 500 mg/kg of 
body weight and 250 mg/kg of body weight has 
maximum percentage of inflammation at 3rd  hour, 
while maximum percentage of inflammation at the 
dosage of 1000 mg/kg of body weight was at 2nd 
hour. 
Antiinflammatory activity of the extract 
started to occur at the 4th hour and was stable until 
5th hour. The resultant calculated inflammatory 
inhibition, can be seen that extract at the dosage 
of 1000 mg/kg of body weight have the highest 
inflammation inhibitory percentage which was 
51.10%. Meanwhile, the positive control group 
showed a inhibition percentage of 73.71%. The 
result was shown at Table 4.
Table 3. Average Inflammatory percentage on Rat Paw for each Test Groups After Carrageenan Induction
CONCLUSION
Based on analgesic (500 mg/kg of body weight 
inhibited 60.28%) and anti-inflammatory (1000 
mg/kg of body weight inhibited 51.10%) 
Time
(Hour)
Inflammatory Percentage (%)
Negative Control
PGA 2 %
Positive Control
Indomethacine 10 mg/
kg of body weight
D I Extract of 
Mimosa pudica L.  1000 
mg/kg of body weight
D II
Extract of  Mimosa 
pudica L.  500 mg/kg  
of body weight
D III
Extract of  Mimosa 
pudica L. 250 mg/kg  
of body weight
1 169. 70 50.58 55.57 35.30 56.28
2 202.97 37.92 123.05 134.43 149
3 225.44 43.13 95.34 136.67* 166.27*
4 179.11 54.01 90.98 125.73* 132.56*
 5 141.63 43.08 83.25 94.14* 90.60*
*shows significant comparison with negative control (p<0.01)
Negative control: PGA Suspension 2%; Positive control: Indomethacine 10 mg/kg bw; D I: Ethanolic extract 1000 mg/kg of body weight; D 
II: Ethanolic extract  500 mg/kg of body weight; D III: Ethanolic extract  250 mg/kg of body weight
Table 4. Average of Inflammation Inhibitory Percentage for 
each Group  
Test Groups Inhibitory Percentage (%)
Indomethacine 10 mg/kg of 
body weight              
Extract of Mimosa pudica L.  
1000 mg/kg of body weight              
Extract of Mimosa pudica L.  
500 mg/kg of body weight              
Extract of Mimosa pudica L.  
250 mg/kg of body weight              
73.71
51.10
42.74
35.20
activities showed by Mimosa pudica L herb 
extract, therefore it is concluded that herbs 
extract of Mimosa pudica L can be proposed as 
antihyperuricemia.
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